Cargando…

Understanding the effects of universal test and treat on longitudinal HIV care outcomes among South African youth: a retrospective cohort study

INTRODUCTION: Little is known about the effects of universal test and treat (UTT) policies on HIV care outcomes among youth living with HIV (YLHIV). Moreover, there is a paucity of information regarding when YLHIV are most susceptible to disengagement from care under the newest treatment guidelines....

Descripción completa

Detalles Bibliográficos
Autores principales: Filiatreau, Lindsey M., Edwards, Jessie K., Masilela, Nkosinathi, Gómez-Olivé, F. Xavier, Haberland, Nicole, Pence, Brian W., Maselko, Joanna, Muessig, Kathryn E., Kabudula, Chodziwadziwa Whiteson, Dufour, Mi-Suk Kang, Lippman, Sheri A., Kahn, Kathleen, Pettifor, Audrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478421/
https://www.ncbi.nlm.nih.gov/pubmed/37670262
http://dx.doi.org/10.1186/s12889-023-16353-9
_version_ 1785101346446245888
author Filiatreau, Lindsey M.
Edwards, Jessie K.
Masilela, Nkosinathi
Gómez-Olivé, F. Xavier
Haberland, Nicole
Pence, Brian W.
Maselko, Joanna
Muessig, Kathryn E.
Kabudula, Chodziwadziwa Whiteson
Dufour, Mi-Suk Kang
Lippman, Sheri A.
Kahn, Kathleen
Pettifor, Audrey
author_facet Filiatreau, Lindsey M.
Edwards, Jessie K.
Masilela, Nkosinathi
Gómez-Olivé, F. Xavier
Haberland, Nicole
Pence, Brian W.
Maselko, Joanna
Muessig, Kathryn E.
Kabudula, Chodziwadziwa Whiteson
Dufour, Mi-Suk Kang
Lippman, Sheri A.
Kahn, Kathleen
Pettifor, Audrey
author_sort Filiatreau, Lindsey M.
collection PubMed
description INTRODUCTION: Little is known about the effects of universal test and treat (UTT) policies on HIV care outcomes among youth living with HIV (YLHIV). Moreover, there is a paucity of information regarding when YLHIV are most susceptible to disengagement from care under the newest treatment guidelines. The longitudinal HIV care continuum is an underutilized tool that can provide a holistic understanding of population-level HIV care trajectories and be used to compare treatment outcomes across groups. We aimed to explore effects of the UTT policy on longitudinal outcomes among South African YLHIV and identify temporally precise opportunities for re-engaging this priority population in the UTT era. METHODS: Using medical record data, we conducted a retrospective cohort study among youth aged 18–24 diagnosed with HIV from August 2015-December 2018 in nine health care facilities in South Africa. We used Fine and Gray sub-distribution proportional hazards models to characterize longitudinal care continuum outcomes in the population overall and stratified by treatment era of diagnosis. We estimated the proportion of individuals in each stage of the continuum over time and the restricted mean time spent in each stage in the first year following diagnosis. Sub-group estimates were compared using differences. RESULTS: A total of 420 YLHIV were included. By day 365 following diagnosis, just 23% of individuals had no 90-or-more-day lapse in care and were virally suppressed. Those diagnosed in the UTT era spent less time as ART-naïve (mean difference=-19.3 days; 95% CI: -27.7, -10.9) and more time virally suppressed (mean difference = 17.7; 95% CI: 1.0, 34.4) compared to those diagnosed pre-UTT. Most individuals who were diagnosed in the UTT era and experienced a 90-or-more-day lapse in care disengaged between diagnosis and linkage to care or ART initiation and viral suppression. CONCLUSIONS: Implementation of UTT yielded modest improvements in time spent on ART and virally suppressed among South African YLHIV— however, meeting UNAIDS’ 95-95-95 targets remains a challenge. Retention in care and re-engagement interventions that can be implemented between diagnosis and linkage to care and between ART initiation and viral suppression (e.g., longitudinal counseling) may be particularly important to improving care outcomes among South African YLHIV in the UTT era. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-16353-9.
format Online
Article
Text
id pubmed-10478421
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104784212023-09-06 Understanding the effects of universal test and treat on longitudinal HIV care outcomes among South African youth: a retrospective cohort study Filiatreau, Lindsey M. Edwards, Jessie K. Masilela, Nkosinathi Gómez-Olivé, F. Xavier Haberland, Nicole Pence, Brian W. Maselko, Joanna Muessig, Kathryn E. Kabudula, Chodziwadziwa Whiteson Dufour, Mi-Suk Kang Lippman, Sheri A. Kahn, Kathleen Pettifor, Audrey BMC Public Health Research INTRODUCTION: Little is known about the effects of universal test and treat (UTT) policies on HIV care outcomes among youth living with HIV (YLHIV). Moreover, there is a paucity of information regarding when YLHIV are most susceptible to disengagement from care under the newest treatment guidelines. The longitudinal HIV care continuum is an underutilized tool that can provide a holistic understanding of population-level HIV care trajectories and be used to compare treatment outcomes across groups. We aimed to explore effects of the UTT policy on longitudinal outcomes among South African YLHIV and identify temporally precise opportunities for re-engaging this priority population in the UTT era. METHODS: Using medical record data, we conducted a retrospective cohort study among youth aged 18–24 diagnosed with HIV from August 2015-December 2018 in nine health care facilities in South Africa. We used Fine and Gray sub-distribution proportional hazards models to characterize longitudinal care continuum outcomes in the population overall and stratified by treatment era of diagnosis. We estimated the proportion of individuals in each stage of the continuum over time and the restricted mean time spent in each stage in the first year following diagnosis. Sub-group estimates were compared using differences. RESULTS: A total of 420 YLHIV were included. By day 365 following diagnosis, just 23% of individuals had no 90-or-more-day lapse in care and were virally suppressed. Those diagnosed in the UTT era spent less time as ART-naïve (mean difference=-19.3 days; 95% CI: -27.7, -10.9) and more time virally suppressed (mean difference = 17.7; 95% CI: 1.0, 34.4) compared to those diagnosed pre-UTT. Most individuals who were diagnosed in the UTT era and experienced a 90-or-more-day lapse in care disengaged between diagnosis and linkage to care or ART initiation and viral suppression. CONCLUSIONS: Implementation of UTT yielded modest improvements in time spent on ART and virally suppressed among South African YLHIV— however, meeting UNAIDS’ 95-95-95 targets remains a challenge. Retention in care and re-engagement interventions that can be implemented between diagnosis and linkage to care and between ART initiation and viral suppression (e.g., longitudinal counseling) may be particularly important to improving care outcomes among South African YLHIV in the UTT era. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-16353-9. BioMed Central 2023-09-05 /pmc/articles/PMC10478421/ /pubmed/37670262 http://dx.doi.org/10.1186/s12889-023-16353-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Filiatreau, Lindsey M.
Edwards, Jessie K.
Masilela, Nkosinathi
Gómez-Olivé, F. Xavier
Haberland, Nicole
Pence, Brian W.
Maselko, Joanna
Muessig, Kathryn E.
Kabudula, Chodziwadziwa Whiteson
Dufour, Mi-Suk Kang
Lippman, Sheri A.
Kahn, Kathleen
Pettifor, Audrey
Understanding the effects of universal test and treat on longitudinal HIV care outcomes among South African youth: a retrospective cohort study
title Understanding the effects of universal test and treat on longitudinal HIV care outcomes among South African youth: a retrospective cohort study
title_full Understanding the effects of universal test and treat on longitudinal HIV care outcomes among South African youth: a retrospective cohort study
title_fullStr Understanding the effects of universal test and treat on longitudinal HIV care outcomes among South African youth: a retrospective cohort study
title_full_unstemmed Understanding the effects of universal test and treat on longitudinal HIV care outcomes among South African youth: a retrospective cohort study
title_short Understanding the effects of universal test and treat on longitudinal HIV care outcomes among South African youth: a retrospective cohort study
title_sort understanding the effects of universal test and treat on longitudinal hiv care outcomes among south african youth: a retrospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478421/
https://www.ncbi.nlm.nih.gov/pubmed/37670262
http://dx.doi.org/10.1186/s12889-023-16353-9
work_keys_str_mv AT filiatreaulindseym understandingtheeffectsofuniversaltestandtreatonlongitudinalhivcareoutcomesamongsouthafricanyoutharetrospectivecohortstudy
AT edwardsjessiek understandingtheeffectsofuniversaltestandtreatonlongitudinalhivcareoutcomesamongsouthafricanyoutharetrospectivecohortstudy
AT masilelankosinathi understandingtheeffectsofuniversaltestandtreatonlongitudinalhivcareoutcomesamongsouthafricanyoutharetrospectivecohortstudy
AT gomezolivefxavier understandingtheeffectsofuniversaltestandtreatonlongitudinalhivcareoutcomesamongsouthafricanyoutharetrospectivecohortstudy
AT haberlandnicole understandingtheeffectsofuniversaltestandtreatonlongitudinalhivcareoutcomesamongsouthafricanyoutharetrospectivecohortstudy
AT pencebrianw understandingtheeffectsofuniversaltestandtreatonlongitudinalhivcareoutcomesamongsouthafricanyoutharetrospectivecohortstudy
AT maselkojoanna understandingtheeffectsofuniversaltestandtreatonlongitudinalhivcareoutcomesamongsouthafricanyoutharetrospectivecohortstudy
AT muessigkathryne understandingtheeffectsofuniversaltestandtreatonlongitudinalhivcareoutcomesamongsouthafricanyoutharetrospectivecohortstudy
AT kabudulachodziwadziwawhiteson understandingtheeffectsofuniversaltestandtreatonlongitudinalhivcareoutcomesamongsouthafricanyoutharetrospectivecohortstudy
AT dufourmisukkang understandingtheeffectsofuniversaltestandtreatonlongitudinalhivcareoutcomesamongsouthafricanyoutharetrospectivecohortstudy
AT lippmansheria understandingtheeffectsofuniversaltestandtreatonlongitudinalhivcareoutcomesamongsouthafricanyoutharetrospectivecohortstudy
AT kahnkathleen understandingtheeffectsofuniversaltestandtreatonlongitudinalhivcareoutcomesamongsouthafricanyoutharetrospectivecohortstudy
AT pettiforaudrey understandingtheeffectsofuniversaltestandtreatonlongitudinalhivcareoutcomesamongsouthafricanyoutharetrospectivecohortstudy